Skip to main content

Published locations for Ustekinumab's Cardiovascular Event Rates Stable at 5 Years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ustekinumab's Cardiovascular Event Rates Stable at 5 Years

User login

  • Reset your password
  • /content/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /edermatologynews/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /familypracticenews/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /internalmedicinenews/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /rheumatologynews/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /rheumatology/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /internalmedicine/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /dermatology/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /familymedicine/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates-stable-5-years
  • /dermatology/psoriasiscollection/article/56719/psoriasis/ustekinumabs-cardiovascular-event-rates